Join
Live feed
·
INSIDERFilingvia Quantisnow
Mineralys Therapeutics Inc. logo

Chief Medical Officer Rodman David Malcom sold $445,982 worth of shares (10,369 units at $43.01), decreasing direct ownership by 13% to 71,155 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MLYS· Mineralys Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MLYS (Mineralys Therapeutics Inc.) and more on Quantisnow.